Home / CDCA7L Knockout Cell Lines

CDCA7L Knockout Cell Lines

Gene: CDCA7L

Official Full Name: cell division cycle associated 7 likeprovided by HGNC

Gene Summary: Acts upstream of or within positive regulation of cell population proliferation. Located in cytosol; fibrillar center; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO18877 CDCA7L Knockout cell line (HeLa) Human CDCA7L 1:3~1:6 Negative Online Inquiry
KO18878 CDCA7L Knockout cell line (HCT 116) Human CDCA7L 1:2~1:4 Negative Online Inquiry
KO18879 CDCA7L Knockout cell line (HEK293) Human CDCA7L 1:3~1:6 Negative Online Inquiry
KO18880 CDCA7L Knockout cell line (A549) Human CDCA7L 1:3~1:4 Negative Online Inquiry

Background

CDCA7L Gene Knockout Cell Lines represent a cutting-edge tool within the field of molecular biology, specifically designed to facilitate the study of the cell division cycle-associated protein 7-like gene (CDCA7L). These cell lines are engineered through the precise application of CRISPR/Cas9 genome editing technology, resulting in a complete knockout of the CDCA7L gene. This targeted approach enables researchers to examine the phenotypic and functional consequences of CDCA7L loss on various cellular processes, including proliferation, apoptosis, and differentiation.

The key function of CDCA7L gene knockout cell lines lies in their ability to provide a platform for in-depth analysis of gene function and regulatory mechanisms. By comparing the knockout lines to wild-type controls, scientists can elucidate the role of CDCA7L in cellular pathways and its potential interactions with other oncogenes or tumor suppressor genes. This is particularly important for understanding cancer biology, as dysregulation of genes like CDCA7L has implications in tumorigenesis and cancer progression.

From a scientific perspective, these knockout cell lines serve as invaluable resources for both basic and applied research. They facilitate drug discovery efforts by providing models to screen for compounds that could restore normal cellular functions or inhibit oncogenic processes. Clinically, insights gained from studies utilizing these cell lines may inform the development of targeted therapies and improve prognostic markers for cancer treatment.

Unlike traditional methods of gene manipulation, the CDCA7L gene knockout cell lines are designed for ease of use and reproducibility, allowing for consistent results across experiments. Their availability comes with detailed technical support and optimization protocols, making them accessible to researchers of varying expertise levels.

The development and commercialization of these innovative cell lines underscore our company's commitment to advancing scientific research and empowering scientists in their pursuit of knowledge. With a strong foundation in molecular biology and a focus on providing high-quality biological products, we are dedicated to supporting the research community with tools that drive discovery and innovation.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.